MedCity News March 7, 2021
While addiction treatment has traditionally focused on the removal of substance use ‘symptoms’ by collecting urine samples and screening for substance use, the complexity of the biopsychosocial framework requires commensurate measurement tooling.
It’s hard to overstate the lasting downstream impact of Covid-19 on Substance Use Disorder (SUD). Already deemed a public health crisis in 2016 by then Surgeon General, Vivek Murthy; the affect stemming from months of social isolation, fear and economic despair is on track to be devastating without a dramatic shift in treatment and payment models.
To date, discussions about how to ‘fix’ this crisis and repair the addiction treatment landscape centered around crucial pieces to the puzzle, namely increased access via telemedicine and removing the “X waiver”,...
Today's Sponsors
Today's Sponsor